Diabetic Macular Edema

Ophthalmology

Volumn 116, Issue 3, 2009, Pages 595-

  Gillies, Mark ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRIAMCINOLONE ACETONIDE;

DIABETIC MACULAR EDEMA; HUMAN; LASER COAGULATION; LETTER; PRIORITY JOURNAL; VISUAL ACUITY;

COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; PRESERVATIVES, PHARMACEUTICAL; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 61349127169     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.12.016     Document Type: Letter

References (2)

1. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 115 (2008) 1447-1449
2. Gillies M.C., Sutter F.K., Simpson J.M., et al. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113 (2006) 1533-1538